Meglumine Iotroxate
Formulations: - Parenteral > General injections > IV: 5 to 8 g iodine (as meglumine) in 100 to 250 mL Indications: - X-ray contrast media, iodinated Source: EML workbook import

Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Formulations: - Parenteral > General injections > IV: 5 to 8 g iodine (as meglumine) in 100 to 250 mL Indications: - X-ray contrast media, iodinated Source: EML workbook import
Formulations: - Oral > Solid > tablet: 50 mg (scored) - Parenteral > General injections > IV: 50 mg in vial powder for injection (as sodium salt); 100 mg in vial powder for injection (as sodium salt) Oral > Liquid: 10 mg per mL Oral > Solid > tablet: 25 mg; 50 mg (scored) Oral > Solid > tablet: 50 mg (scored) Indications: - Rheumatoid arthritis, serology unspecified - Psoriatic arthritis - Failure or rejection of transplanted organs or tissues - Relapsing-remitting multiple sclerosis Source: EML workbook import
Formulations: - Oral > Solid: 200 mg (as sulfate) Indications: - Systemic lupus erythematosus - Cutaneous lupus erythematosus of unspecified type Source: EML workbook import
Formulations: - Local > Topical > Solution: 80% v/v ethanol; 75% v/v isopropyl alcohol Indications: - Denatured alcohol Source: EML workbook import
Formulations: - Local > Topical > Powder: 0.1% available chlorine for solution Local > Topical > Liquid: 0.1% available chlorine for solution Local > Topical > Solid: 0.1% available chlorine for solution Indications: - Disinfectant, not elsewhere classified Source: EML workbook import
Formulations: - Local > Topical > Solution: 4.8% Indications: - Phenol disinfectant, not elsewhere classified Source: EML workbook import
Formulations: - Local > Topical > Solution: 2% Indications: - Glutaral nonmedicinal Source: EML workbook import
Formulations: - Solution (aqueous): containing hypochlorous acid ≥ 150 parts per million Indications: - Disinfectant, not elsewhere classified Source: EML workbook import
Formulations: - Oral > Solid: 5 mg (hydrochloride) Indications: - Oedema - Ascites Source: EML workbook import
Indications: - Anuria or oliguria - Oedema - Heart failure Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 10 mg per mL in 2 mL ampoule; 10 mg per mL in 5 mL ampoule Oral > Liquid: 20 mg per 5 mL; 50 mg per 5 mL Oral > Solid > tablet: 40 mg; 20 mg Indications: - Anuria or oliguria - Oedema - Heart failure Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 10% solution; 20% solution Indications: - Ocular hypertension - Cerebral oedema Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.